1970-2022年美国因吸烟率下降而避免的肺癌死亡
该研究基于1970-2022年美国国家卫生统计中心死亡数据,按年份、年龄、性别、种族和年龄组计算预期肺癌死亡数,减去观察死亡数得出避免的肺癌死亡数及获得的生命年。估计1970-2022年共避免3,856,240例肺癌死亡,获得76,275,550生命年,避免的肺癌死亡占总体癌症死亡下降的51.4%。
要点
- 1970-2022年美国估计避免3,856,240例肺癌死亡(男性2,246,610例,女性1,609,630例)。
- 同期获得76,275,550生命年,每例避免死亡平均获得19.8生命年。
- 避免的肺癌死亡占总体癌症死亡下降的51.4%,男性60.1%高于女性42.7%。
核心结论
- 估计的大量避免肺癌死亡和获得生命年凸显了控烟对减少肺癌过早死亡的可观效果。
研究设计与样本
- 使用1970-2022年美国国家卫生统计中心死亡数据(全国覆盖),按年份、年龄、性别、种族和年龄组计算预期死亡数。
- 避免的肺癌死亡数通过各组观察死亡数减去预期死亡数计算。
- 获得生命年基于若未死于肺癌的平均额外生存年数估计。
主要发现
- 1970-2022年估计避免3,856,240例肺癌死亡(男性2,246,610例,女性1,609,630例)。
- 同期获得76,275,550生命年(男性40,277,690,女性35,997,860),每例避免死亡平均获得19.8生命年(男性17.9,女性22.4)。
- 避免的肺癌死亡占总体癌症死亡下降的51.4%,男性60.1%高于女性42.7%。
- 按种族,白人比例为53.6%(男性62.8%,女性44.6%),黑人比例为40.0%(男性44.4%,女性34.7%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung cancer mortality rates in the United States have declined steeply in recent decades, largely because of substantial reductions in smoking prevalence, as approximately 85% of lung cancer deaths are attributable to cigarette smoking. In this study, the authors estimate the number of averted lung cancer deaths and corresponding person-years of life gained during 1970-2022 as a measure of progress in cancer prevention through tobacco control. By using the 1970-2022 National Center for Health Statistics mortality data (with national coverage), the authors calculated the expected number of deaths for each year, age, sex, race, and age group based on the expected lung cancer death rate multiplied by the population at risk in that group. The number of averted lung cancer deaths were calculated by subtracting the observed number of deaths from the expected number in each group. Person-years of life gained were estimated as a measure of avoided premature mortality based on the average additional years a person would have lived if they had not died from lung cancer. The authors estimated that 3,856,240 lung cancer deaths (2,246,610 in men, 1,609,630 in women) were averted, and 76,275,550 person-years of life (40,277,690 in men, 35,997,860 in women) were gained during 1970-2022, with an average of 19.8 person-years of life gained (17.9 in men, 22.4 in women) per averted death. The number of averted lung cancer deaths accounted for 51.4% of the estimated declines in overall cancer deaths and was substantially greater in men (60.1%) than in women (42.7%). By race, this proportion was 53.6% in the White population (62.8% in men, 44.6% in women) and 40.0% in the Black population (44.4% in men, 34.7% in women). The substantial estimated numbers of averted lung cancer deaths and person-years of life gained highlight the remarkable effect of progress against smoking on reducing premature mortality from lung cancer.
引用
- Islami F, Nargis N, Liu Q, et al. Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970-2022. CA Cancer J Clin. 2025. PMID: 40131130. doi:10.3322/caac.70005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。